PARTICIPA

PARTICIPA

miércoles, 21 de febrero de 2024

Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease | Hepatobiliary Disease | JAMA Internal Medicine | JAMA Network

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2814646

Enviado desde mi iPhone

No hay comentarios:

Publicar un comentario

Danos tu opinion, enriquece el post.